Correlation Between Vg Life and Ascletis Pharma

Can any of the company-specific risk be diversified away by investing in both Vg Life and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vg Life and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vg Life Sciences and Ascletis Pharma, you can compare the effects of market volatilities on Vg Life and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vg Life with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vg Life and Ascletis Pharma.

Diversification Opportunities for Vg Life and Ascletis Pharma

0.11

Correlation Coefficient

Vg Life  Ascletis Pharma

Average diversification

The 3 months correlation between VGLS and Ascletis is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Vg Life Sciences and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and Vg Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vg Life Sciences are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of Vg Life i.e., Vg Life and Ascletis Pharma go up and down completely randomly.

Pair Corralation between Vg Life and Ascletis Pharma

Given the investment horizon of 90 days Vg Life Sciences is expected to under-perform the Ascletis Pharma. But the pink sheet apears to be less risky and, when comparing its historical volatility, Vg Life Sciences is 1.68 times less risky than Ascletis Pharma. The pink sheet trades about -0.22 of its potential returns per unit of risk. The Ascletis Pharma is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  24.00  in Ascletis Pharma on December 2, 2024 and sell it today you would earn a total of  60.00  from holding Ascletis Pharma or generate 250.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Vg Life Sciences  vs.  Ascletis Pharma

Vg Life Sciences

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vg Life Sciences are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile essential indicators, Vg Life unveiled solid returns over the last few months and may actually be approaching a breakup point.

Ascletis Pharma

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ascletis Pharma are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Ascletis Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vg Life and Ascletis Pharma

The main advantage of trading using opposite Vg Life and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vg Life position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.

The idea behind Vg Life Sciences and Ascletis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.